Showing results (1-10 of 233) with videos related to
Sort By:
Pageof 24
Arthritis Research & Therapy|October 7, 2005
DAS28: a useful instrument to monitor infliximab treatment in patients with rheumatoid arthritisPiet L C M van Riel, Jaap FransenArthritis Research & Therapy|October 24, 2009
Outcome measures in inflammatory rheumatic diseasesJaap Fransen, Piet L C M van RielRheumatic Diseases Clinics of North America|December 8, 2009
The Disease Activity Score and the EULAR response criteriaJaap Fransen, Piet L C M van RielBest Practice & Research. Clinical Rheumatology|May 5, 2004
Are better endpoints and better design of clinical trials needed?Jaap Fransen, Piet L C M van RielRMD Open|December 3, 2015
Monitoring rheumatoid arthritis using an algorithm based on patient-reported outcome measures: a first step towards personalised healthcareJos Hendrikx, Jaap Fransen, Piet L C M van RielQuality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 26, 2014
Individual patient monitoring in daily clinical practice: a critical evaluation of minimal important changeJos Hendrikx, Jaap Fransen, Wietske Kievit, et al.Rheumatology (Oxford, England)|March 25, 2016
The influence of patient perceptions of disease on medication intensification in daily practiceJos Hendrikx, Wietske Kievit, Jaap Fransen, et al.Arthritis and Rheumatism|September 6, 2005
Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritisPaco M J Welsing, Jaap Fransen, Piet L C M van RielThe Journal of Rheumatology|January 17, 2015
A simplified baseline prediction model for joint damage progression in rheumatoid arthritis: a step toward personalized medicineYvonne M R de Punder, Piet L C M van Riel, Jaap FransenRheumatology (Oxford, England)|May 22, 2009
Methotrexate in combination with sulfasalazine is more effective in rheumatoid arthritis patients who failed sulfasalazine than in patients naive to both drugsLydia G Schipper, Jaap Fransen, Pilar Barrera, et al.Pageof 24